Showing results (101-110 of 1,983) with videos related to

Sort By:
Pageof 199
Peerj|March 4, 2025
Development of a prognostic model based on the ceRNA network in Triple-Negative Breast cancerYimin Zhu, Jiayu Wang, Binghe Xu
Clinical Breast Cancer|February 7, 2021
Primary Trastuzumab Resistance After (Neo)adjuvant Trastuzumab-containing Treatment for Patients With HER2-positive Breast Cancer in Real-world PracticeXuelian Chen, Jiayu Wang, Ying Fan, et al.
Breast Cancer (Dove Medical Press)|August 27, 2025
Safety Profile and Predictors of Adverse Events of Incadronate Disodium in Treating Breast Cancer Patients with Bone Metastases: A Retrospective StudyShihan Zhou, Mingxia Jiang, Jiaxuan Liu, et al.
Oncotarget|February 17, 2017
Young breast cancer patients who develop distant metastasis after surgery have better survival outcomes compared with elderly counterpartsJingjing Wang, Jiayu Wang, Qing Li, et al.
Thoracic Cancer|April 3, 2025
Clinicopathological Factors That Predict Different Responses of Breast and Axillary Tumors to Neoadjuvant Chemotherapy and Prognosis Among Patients With Node-Positive Breast Cancer: Real World DataDanyang Ji, Bo Lan, Jiayu Wang, et al.
Medicine|May 6, 2016
Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese PopulationJiayu Wang, Die Sang, Binghe Xu, et al.
Medcomm|December 1, 2025
High-Plex Digital Spatial Profiling Identified Prolactin-Induced Protein mRNA Associated With Response and Survival of Everolimus and Letrozole Treatment for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerYuhang Han, Danyang Ji, Yujing Tan, et al.
Oncotarget|September 8, 2016
ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapyFei Ma, Wenjie Zhu, Yanfang Guan, et al.
Biomarker Research|February 21, 2023
Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studiesXiuwen Guan, Fei Ma, Qiao Li, et al.
Medicine|October 30, 2015
Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane TreatmentMeiying Li, Ying Fan, Qing Li, et al.
Pageof 199